Drug Sorafenib Improves Kidney Cancer Outcomes, Addenbrooke's Hospital And University of Cambridge Study
MedPage Today -- CAMBRIDGE, England, Oct. 7 -- For advanced renal cell carcinoma, sorafenib (Nexavar) improves outcomes in both younger and older patients, according to a post-hoc analysis.